269 related articles for article (PubMed ID: 30039492)
21. The differential expression patterns and co-expression networks of paralogs as an indicator of the TNM stages of lung adenocarcinoma and squamous cell carcinoma.
Lian S; Liu Z; Zhou Y; Guo J; Gong K; Wang T
Genomics; 2020 Nov; 112(6):4115-4124. PubMed ID: 32659329
[TBL] [Abstract][Full Text] [Related]
22. High Expression of
Zhao T; Qian K; Zhang Y
J Comput Biol; 2020 Jun; 27(6):948-957. PubMed ID: 31553229
[TBL] [Abstract][Full Text] [Related]
23. Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Su X; Wan Y; Xie L; Lin X; Zhao H; Ju X; Fang A
Med Sci Monit; 2019 Sep; 25():6691-6701. PubMed ID: 31489957
[TBL] [Abstract][Full Text] [Related]
24. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
Hou G; Lu Z; Bi Y; Deng J; Yang X
Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma.
Ma X; Yang S; Jiang H; Wang Y; Xiang Z
J Transl Med; 2021 Aug; 19(1):368. PubMed ID: 34446056
[TBL] [Abstract][Full Text] [Related]
27. Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods.
Chen JW; Dhahbi J
Sci Rep; 2021 Jun; 11(1):13323. PubMed ID: 34172784
[TBL] [Abstract][Full Text] [Related]
28. Construction of a transcription factor‑long non‑coding RNA‑microRNA network for the identification of key regulators in lung adenocarcinoma and lung squamous cell carcinoma.
Zhao S; Chen H; Ding B; Li J; Lv F; Han K; Zhou D; Yu B; Yu Y; Zhang W
Mol Med Rep; 2019 Feb; 19(2):1101-1109. PubMed ID: 30569133
[TBL] [Abstract][Full Text] [Related]
29. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G
Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
Kaishang Z; Xue P; Shaozhong Z; Yingying F; Yan Z; Chanjun S; Zhenzhen L; Xiangnan L
Life Sci; 2018 Dec; 215():159-169. PubMed ID: 30391462
[TBL] [Abstract][Full Text] [Related]
31. Differential Expression of AP-2 Transcription Factors Family in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma-A Bioinformatics Study.
Szmajda-Krygier D; Krygier A; Żebrowska-Nawrocka M; Pietrzak J; Świechowski R; Wosiak A; Jeleń A; Balcerczak E
Cells; 2023 Feb; 12(4):. PubMed ID: 36831334
[TBL] [Abstract][Full Text] [Related]
32. Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
Zhang Y; Chang L; Yang Y; Fang W; Guan Y; Wu A; Hong S; Zhou H; Chen G; Chen X; Zhao S; Zheng Q; Pan H; Zhang L; Long H; Yang H; Wang X; Wen Z; Wang J; Yang H; Xia X; Zhao Y; Hou X; Ma Y; Zhou T; Zhang Z; Zhan J; Huang Y; Zhao H; Zhou N; Yi X; Zhang L
Mol Cancer; 2019 Jan; 18(1):7. PubMed ID: 30626401
[TBL] [Abstract][Full Text] [Related]
33. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
Yin D; Zhang Y; Li H; Cheng L
Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446
[TBL] [Abstract][Full Text] [Related]
34. Identification of the cell cycle characteristics of non-small cell lung cancer and its relationship with tumor immune microenvironment, cell death pathways, and metabolic reprogramming.
Cao S; Xiao S; Zhang J; Li S
Front Endocrinol (Lausanne); 2023; 14():1147366. PubMed ID: 37091844
[TBL] [Abstract][Full Text] [Related]
35. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma.
Wu X; Ruan L; Yang Y; Mei Q
Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440
[TBL] [Abstract][Full Text] [Related]
36. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
Chen WJ; Gan TQ; Qin H; Huang SN; Yang LH; Fang YY; Li ZY; Pan LJ; Chen G
Pathol Res Pract; 2017 Apr; 213(4):364-372. PubMed ID: 28214218
[TBL] [Abstract][Full Text] [Related]
37. Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
Rice SJ; Liu X; Hyland V; Liu Z; Belani CP
Lung Cancer; 2020 Mar; 141():97-100. PubMed ID: 31986371
[TBL] [Abstract][Full Text] [Related]
38. Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response.
Lucchetta M; da Piedade I; Mounir M; Vabistsevits M; Terkelsen T; Papaleo E
BMC Cancer; 2019 Aug; 19(1):824. PubMed ID: 31429720
[TBL] [Abstract][Full Text] [Related]
39. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
40. Network module function enrichment analysis of lung squamous cell carcinoma and lung adenocarcinoma.
Li P; Yuan H; Kuang X; Zhang T; Ma L
Medicine (Baltimore); 2022 Nov; 101(47):e31798. PubMed ID: 36451444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]